课题基金 / 基金详情

SELF ASSOCIATION OF PROTEINS (SIMSTEX): DEVELOPMENT & APPLICATON

SELF ASSOCIATION OF PROTEINS (SIMSTEX): DEVELOPMENT & APPLICATON
蛋白质自缔合 (SIMSTEX):开发
批准号:
7721448
负责人:
MICHAEL L GROSS
金额:
$0.04万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-02-01 至 2009-01-31

项目摘要

项目成果

MICHAEL L GROSS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Protein-protein interactions are crucial for many biological functions in living systems Disruptions in these interactions can lead to various diseases including metabolic disorders, cancer and infections. The propensity of various insulins and their analogs to oligomerize can be investigated by mass spectrometric methods including measurement of the relative abundances of oligomers in the gas phase and the kinetics of H/D amide exchange. The kinetics of deuterium uptake show a good fit when the exchanging amides are placed in three kinetic groups: fast, intermediate, and slow. r-Human insulin, of the insulins investigated, has fewer amides that exchange at intermediate rates and more that exchange at slow rates, in accord with its higher extent of assocn. in soln. We adapted PLIMSTEX (protein ligand interactions by mass spectrometry, titrn., and H/D exchange) to det. protein/ligand affinities in soln., to det. self-assocn. equil. consts. for proteins, and to apply them to various insulin analogs. We term this adaptation SIMSTEX (self-assocn. interactions using mass spectrometry, self-titrn. and H/D exchange); it gives affinity consts. that compare well with the literature results. The results from SIMSTEX show that some mutants (e.g., GlnB13) have an increased tendency to self-assoc., possibly slowing down their action in vivo. Other mutants (e.g., lispro and AspB9) have lower propensities for self-assocn., thus providing potentially faster-acting analogs for use in controlling diabetes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Biomedical Mass Spectrometry Resource: Ongoing Driving Biomedical Projects
  • 批准号:
    10441142
  • 项目类别:
  • 资助金额:
    $65.99万
  • 财政年份:
    2020
  • 负责人:
    MICHAEL L GROSS
  • 依托单位:
New chemical probes enable Mass Spectrometry-based footprinting of human protein structure in lipid membranes and cells
  • 批准号:
    10350642
  • 项目类别:
  • 资助金额:
    $40.98万
  • 财政年份:
    2019
  • 负责人:
    MICHAEL L GROSS
  • 依托单位:
NEW CHEMICAL PROBES ENABLE MASS SPECTROMETRY-BASED FOOTPRINTING OF HUMAN PROTEIN STRUCTURE IN LIPID
  • 批准号:
    10390166
  • 项目类别:
  • 资助金额:
    $25.0万
  • 财政年份:
    2019
  • 负责人:
    MICHAEL L GROSS
  • 依托单位:
NEW CHEMICAL PROBES ENABLE MASS SPECTROMETRY-BASED FOOTPRINTING OF HUMAN PROTEIN STRUCTURE IN LIPID MEMBRANES AND CELLS
  • 批准号:
    10587527
  • 项目类别:
  • 资助金额:
    $46.57万
  • 财政年份:
    2019
  • 负责人:
    MICHAEL L GROSS
  • 依托单位:
海外基金